WallStSmart

Hinge Health, Inc. (HNGE)vsNational Research Corp (NRC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hinge Health, Inc. generates 366% more annual revenue ($646.34M vs $138.64M). NRC leads profitability with a 6.5% profit margin vs -78.9%. NRC earns a higher WallStSmart Score of 48/100 (D+).

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 5.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.69

NRC

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 7.5Value: 6.7Quality: 3.0
Piotroski: 3/9Altman Z: 1.32
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HNGE.

NRCUndervalued (+50.5%)

Margin of Safety

+50.5%

Fair Value

$27.80

Current Price

$19.75

$8.05 discount

UndervaluedFair: $27.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.2%10/10

Revenue surging 47.2% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

NRC1 strengths · Avg: 10.0/10
Return on EquityProfitability
66.9%10/10

Every $100 of equity generates 67 in profit

Areas to Watch

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
43.4x2/10

Trading at 43.4x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

NRC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.7%4/10

3.7% revenue growth

Market CapQuality
$431.35M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.5%3/10

6.5% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 47.2% demonstrates continued momentum.

Bull Case : NRC

The strongest argument for NRC centers on Return on Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Bear Case : NRC

The primary concerns for NRC are Revenue Growth, Market Cap, Profit Margin. A P/E of 49.1x leaves little room for execution misses. Debt-to-equity of 5.78 is elevated, increasing financial risk.

Key Dynamics to Monitor

HNGE profiles as a hypergrowth stock while NRC is a value play — different risk/reward profiles.

HNGE is growing revenue faster at 47.2% — sustainability is the question.

HNGE generates stronger free cash flow (43M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NRC scores higher overall (48/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

National Research Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

National Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.

Want to dig deeper into these stocks?